Back to Results
| First Page | Meta Content | |
|---|---|---|
 | Open DocumentFile Size: 916,33 KBShare Result on FacebookCityWashington DC / Baltimore / New York / /CompanyAgency for Health Care Policy / Raven Press / New England Journal / John Wiley & Sons / American Psychiatric Press / RAND Corporation / /FacilityNational Institute of Mental Health / Department of Veterans Affairs Northeast Program Evaluation Center / University of Maryland Center / PORT Project Abstract Beginning / Maryland Psychiatric Research Center / University of Maryland / Johns Hopkins University / PORT Treatment Recommendations / University of Maryland School / Yale University / University School / /IndustryTermtreatment of positive symptoms / health services / education services / social services / postemployment services / chemical / vocational services / assertive case management / /MedicalConditionpersistent depression / movement disorder / hallucinations / schizoaffective disorder / dyskinesia / Severe Mental Illness / cardiac arrhythmia / depressive illness / severe tardive dyskinesia / neuroleptic malignant syndrome / illness / affective disorders / substantially less tardive dyskinesia / J.M. Schizophrenia / chronic schizophrenia / paranoia / family dysfunction / agranulocytosis / persistent dystonia / schizophrenia / respiratory depression / acute schizophrenia / Catatonic schizophrenia / patient's schizophrenic disorder / depression / severe and chronic schizophrenia / tardive dyskinesia / akathisia / /MedicalTreatmentrehabilitation counseling / pharmacotherapies / counseling / electroconvulsive therapy / Adjunctive therapy / psychotherapy / pharmacotherapy / /OrganizationEditorial Advisory Board of the Bulletin / Center for Research / University of Maryland / the Johns Hopkins University School of Public Health / Johns Hopkins University / Department of Health Policy and Management / Investigators of the PORT Project Abstract Beginning / University of Maryland Center for Mental Health Services Research / Yale University / University of Maryland School of Pharmacy / Department of Veterans Affairs Northeast Program Evaluation Center / Agency for Health Care Policy and Research / University School of Hygiene and Public Health / Maryland Psychiatric Research Center / The Johns Hopkins University School of Hygiene and Public Health / University of Maryland School of Medicine / National Institute of Mental Health / /PersonElizabeth Ann Skinner / Robert Rosenheck / Maureen Fahey / Judith Ann Kasper / Alan Lyles / Jack E. Scott / Lisa B. Dixon / Howard H. Goldman / Donald M. Steinwachs / William T. Carpenter / Fred Osher / Jerome Levine / Leticia Postrado / Elizabeth Ann McGlynn / Robert Buchanan / June Zito / Anthony F. Lehman / Pamela Fischer / A.F. Lehman / /Positionjob coach / mediator / Co-Investigator / Professor of Health Policy and Management and Chair / physician / Co-Director / Principal Investigator of the Schizophrenia Patient Outcomes Research Team / employment specialist / Co-Principal Investigator / Professor of Psychiatry / /ProductFluphenazine / Haloperidol / Loxapine / fluphenazine hydrochloride / carbamazepine / Risperidone / fluphenazine decanoate / CPZ-equlvalence multiplier2 CPZ equivalence1 Medication / Haloperidol decanoate / olanzapine / clozapine / Thiothixene / Perphenazine / Prochlorperazine / /ProvinceOrStateMaryland / /PublishedMediumBritish Journal of Psychiatry / New England Journal of Medicine / the Schizophrenia Bulletin / the Bulletin / /RegionNew England / /Technologydrug metabolism / pharmacokinetics / /URLhttp /SocialTag |